MPO and breast carcinoma: Higher levels of CXC-receptor and ligands in chemotherapy-resistant breast cancer patients suggest the recruitment of a higher number of neutrophils, characterized by the MPO gene, to the tumor sites of chemotherapy-resistant patients.